Pandemrix News
Most Popular Pandemrix Story
GSK's $3.2B bet on pandemic pays off
GlaxoSmithKline has been all over the news lately, as the drugmaker racks up order after order for its pandemic flu vaccine. But it's not just the vaccine that's boosting Glaxo's pandemic sales. The Read more...
Latest Headlines
- July 22, 2011
- February 9, 2011
- December 17, 2010
- May 28, 2010
- October 9, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
